Endpoint definition
↥| Name | GENERALI_SKIN_ERUPT_DRUGS_MEDICAM |
|---|---|
| Long name | Generalized skin eruption due to drugs and medicaments |
| Hospital Discharge registry | ICD-10: L270 |
| Level in the ICD-hierarchy | C |
| First defined in version | DF5 |
| Name | GENERALI_SKIN_ERUPT_DRUGS_MEDICAM |
|---|---|
| Long name | Generalized skin eruption due to drugs and medicaments |
| Hospital Discharge registry | ICD-10: L270 |
| Level in the ICD-hierarchy | C |
| First defined in version | DF5 |
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 481 | 320 | 161 |
| Unadjusted prevalence (%) | 0.22 | 0.26 | 0.17 |
| Mean age at first event (years) | 51.77 | 50.75 | 53.80 |
| Case fatality at 5-years (%) | 4.99 | 4.69 | 5.59 |
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 1.0 | 1.0 | 1.0 |
| Recurrence at 6 months (%) | 14.14 | 15.00 | 12.42 |
before Generalized skin eruption due to drugs and medicaments
after Generalized skin eruption due to drugs and medicaments
Loading survival analyses plot…
Loading survival analyses table…